Post by
mercedesman on Oct 03, 2022 1:38pm
He who lands PMX may also land a 1st-line therapy for CV-19
New Japanese Study
Efficacy and Safety of Direct Hemoperfusion using Polymyxin B-Immobilized Polystyrene Column (PMX-DHP) for COVID-19 Patients: Exploratory Study Protocol
Polymyxin B-immobilized fiber column (PMX, Toraymyxin column) was approved for the relief of SIRS (systemic inflammatory response syndrome) caused by bacterial infection or endotoxemia. PMX reduces lung damage by removing leukocytes and cytokines in addition to endotoxin removal, in the setting of idiopathic pulmonary fibrosis....
Clinical trials are being conducted but, with the exception of remdesivir and dexamethasone, no treatments have yet been approved. COVID-19 aggravates with the deterioration of oxygen saturation, decrease in lymphocytes and the occurrence of an abnormal congealing fibrinogenolysis system, leading to diffuse lung damage. Once the condition transitions from moderate to severe, it is most necessary to prevent further exacerbation by providing treatment that will suppress the above symptoms as soon as possible....
CONCLUSIONS: From a clinical perspective, PMX-DHP is expected to become a first-line therapy to address unmet medical needs and prevent the exacerbation from moderate to severe ARDS (acute respiratory distress syndrome) in COVID-19 cases.
https://read.qxmd.com/read/36126219/efficacy-and-safety-of-direct-hemoperfusion-using-polymyxin-b-immobilized-polystyrene-column-pmx-dhp-for-covid-19-patients-exploratory-study-protocol
Comment by
oilandgasman on Oct 03, 2022 2:22pm
Hello American FDA..... wake up
Comment by
Revten on Oct 03, 2022 4:18pm
Bought a Nice Chunch Of Shares at .38 this morning! Thanks to those who Graciously Let Them Go! Man!...what a STEAL! Anything under $1.00 a Share is Very Good! Under .50 Cents is an ABSOLUTE STEAL!! Still Buying and Very REVED UP! Best To All!